0.2511 USD
-0.01 (-3.42%)
0.2689 USD
+0.02 (+7.09%)
VNRX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. VNRX has a bad profitability rating. Also its financial health evaluation is rather negative. VNRX is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
- In the past year VNRX has reported negative net income.
- In the past year VNRX has reported a negative cash flow from operations.
- In the past 5 years VNRX always reported negative net income.
- In the past 5 years VNRX always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -267.93%, VNRX is doing worse than 92.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -267.93% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-192.89%
ROA(5y)-150.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for VNRX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- VNRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- VNRX has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for VNRX has been increased compared to 5 years ago.
- The debt/assets ratio for VNRX is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -47.91, we must say that VNRX is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of VNRX (-47.91) is worse than 91.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -47.91 |
ROIC/WACCN/A
WACC9.96%
2.3 Liquidity
- VNRX has a Current Ratio of 0.35. This is a bad value and indicates that VNRX is not financially healthy enough and could expect problems in meeting its short term obligations.
- VNRX's Current ratio of 0.35 is on the low side compared to the rest of the industry. VNRX is outperformed by 93.48% of its industry peers.
- A Quick Ratio of 0.35 indicates that VNRX may have some problems paying its short term obligations.
- VNRX's Quick ratio of 0.35 is on the low side compared to the rest of the industry. VNRX is outperformed by 93.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.35 | ||
| Quick Ratio | 0.35 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 36.11% over the past year.
- The Revenue has grown by 59.10% in the past year. This is a very strong growth!
- VNRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 128.05% yearly.
EPS 1Y (TTM)36.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.57%
Revenue 1Y (TTM)59.1%
Revenue growth 3Y139.31%
Revenue growth 5Y128.05%
Sales Q2Q%32.19%
3.2 Future
- The Earnings Per Share is expected to grow by 41.40% on average over the next years. This is a very strong growth
- Based on estimates for the next years, VNRX will show a very strong growth in Revenue. The Revenue will grow by 149.33% on average per year.
EPS Next Y29.96%
EPS Next 2Y26.69%
EPS Next 3Y30.17%
EPS Next 5Y41.4%
Revenue Next Year5.02%
Revenue Next 2Y133.78%
Revenue Next 3Y206.25%
Revenue Next 5Y149.33%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- VNRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VNRX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- VNRX's earnings are expected to grow with 30.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.69%
EPS Next 3Y30.17%
5. Dividend
5.1 Amount
- VNRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
VOLITIONRX LTD / VNRX FAQ
What is the ChartMill fundamental rating of VOLITIONRX LTD (VNRX) stock?
ChartMill assigns a fundamental rating of 2 / 10 to VNRX.
What is the valuation status of VOLITIONRX LTD (VNRX) stock?
ChartMill assigns a valuation rating of 1 / 10 to VOLITIONRX LTD (VNRX). This can be considered as Overvalued.
Can you provide the profitability details for VOLITIONRX LTD?
VOLITIONRX LTD (VNRX) has a profitability rating of 0 / 10.